descriptionPublicationkeyboard_double_arrow_right Article 01 Nov 1972 English Publisher:Elsevier BVJournal:The American Journal of Medicine, volume 53, pages 693-696 (issn: 0002-9343,

Authors: Robert M. Pilewski; Joseph D. Sapira; Lawrence D. Ellis; Raymond Mark;

doi: 10.1016/0002-9343(72)90165-9

pmid: 5079767

Oxyphenbutazone and aplastic anemia

- Summary
- Subjects
- Metrics

Abstract

Abstract Described here is a patient with rheumatoid arthritis in whom aplastic anemia developed while he was taking oxyphenbutazone. Although few cases of hematologic toxicity have been reported in association with this drug, the hazard is probably comparable to that with phenylbutazone.

Keywords

Adult, Arthritis, Rheumatoid, Male, Anemia, Aplastic, Humans, Oxyphenbutazone

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	7
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average